{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:20:40Z","timestamp":1758381640908,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.xphs.2023.12.009","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T17:12:20Z","timestamp":1702573940000},"page":"587-595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Stabilities and Antiviral Activities of Chemically Modified Peptides Against Dengue Serotypes 1\u20134"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9602-3671","authenticated-orcid":false,"given":"Michelle Felicia","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7895-9110","authenticated-orcid":false,"given":"Mohd Ishtiaq","family":"Anasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8475-6291","authenticated-orcid":false,"given":"Chit Laa","family":"Poh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xphs.2023.12.009_bib0001","doi-asserted-by":"crossref","first-page":"e2093","DOI":"10.1002\/rmv.2093","article-title":"Prevalence and burden of dengue infection in Europe: a systematic review and meta-analysis","volume":"30","author":"Ahmed","year":"2020","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.xphs.2023.12.009_bib0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijid.2021.04.010","article-title":"Co-circulation of three dengue virus serotypes led to a severe dengue outbreak in Xishuangbanna, a border area of China, Myanmar, and Laos, in 2019","volume":"107","author":"Zhang","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1016\/j.xphs.2023.12.009_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008349","article-title":"Dengue in a crowded megacity: lessons learnt from 2019 outbreak in Dhaka, Bangladesh","volume":"14","author":"Hossain","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"22","key":"10.1016\/j.xphs.2023.12.009_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26226768","article-title":"Updates on dengue vaccine and antiviral: where are we heading?","volume":"26","author":"Norshidah","year":"2021","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.xphs.2023.12.009_bib0005","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41564-019-0476-8","article-title":"The current and future global distribution and population at risk of dengue","volume":"4","author":"Messina","year":"2019","journal-title":"Nat Microbiol"},{"issue":"6","key":"10.1016\/j.xphs.2023.12.009_bib0006","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrmicro3030","article-title":"Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis","volume":"11","author":"St John","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.xphs.2023.12.009_bib0007","series-title":"Dengue Virus. Emerging and Reemerging Viral Pathogens: Copyright \u00a9 2020","first-page":"281","author":"Murugesan","year":"2020"},{"key":"10.1016\/j.xphs.2023.12.009_bib0008","doi-asserted-by":"crossref","first-page":"507","DOI":"10.13005\/bbra\/2854","article-title":"Dengue vector control: a review for wolbachia-based strategies","volume":"17","author":"Alkuriji","year":"2020","journal-title":"Biosci Biotechnol Res Asia"},{"issue":"1","key":"10.1016\/j.xphs.2023.12.009_bib0009","doi-asserted-by":"crossref","first-page":"9534","DOI":"10.1038\/s41598-020-66212-5","article-title":"Knowledge, attitude and practice on dengue prevention and dengue seroprevalence in a dengue hotspot in Malaysia: a cross-sectional study","volume":"10","author":"Selvarajoo","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xphs.2023.12.009_bib0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.xphs.2023.12.009_bib0011","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.euprot.2014.05.003","article-title":"The emergence of peptides in the pharmaceutical business: from exploration to exploitation","volume":"4","author":"Uhlig","year":"2014","journal-title":"EuPA Open Proteom"},{"issue":"6","key":"10.1016\/j.xphs.2023.12.009_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178943","article-title":"Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum","volume":"12","author":"B\u00f6ttger","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.xphs.2023.12.009_bib0013","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.inf.0000133045.45316.6a","article-title":"Long term tolerability and safety of enfuvirtide for human immunodeficiency virus 1-infected children","volume":"23","author":"Church","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.xphs.2023.12.009_bib0014","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1208\/s12248-014-9687-3","article-title":"Strategic approaches to optimizing peptide ADME properties","volume":"17","author":"Di","year":"2015","journal-title":"AAPS J"},{"issue":"9","key":"10.1016\/j.xphs.2023.12.009_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012684","article-title":"Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs","volume":"5","author":"Nguyen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.xphs.2023.12.009_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2021.198456","article-title":"Stability and antiviral activity of SP40 peptide in human serum","volume":"303","author":"Zarif","year":"2021","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.009_bib0017","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11095-023-03486-0","article-title":"Strategies to improve the physicochemical properties of peptide-based drugs","volume":"40","author":"Lee","year":"2023","journal-title":"Pharm Res"},{"issue":"9","key":"10.1016\/j.xphs.2023.12.009_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/v11090811","article-title":"Long-acting HIV-1 fusion inhibitory peptides and their mechanisms of action","volume":"11","author":"Wang","year":"2019","journal-title":"Viruses"},{"issue":"25","key":"10.1016\/j.xphs.2023.12.009_bib0019","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1021\/acs.jafc.7b01238","article-title":"Antifungal and antiviral cyclic peptides from the deep-sea-derived fungus Simplicillium obclavatum EIODSF 020","volume":"65","author":"Liang","year":"2017","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.xphs.2023.12.009_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2023.01.016","article-title":"Development of novel antiviral peptides against dengue serotypes 1-4","volume":"580","author":"Lee","year":"2023","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.xphs.2023.12.009_bib0021","doi-asserted-by":"crossref","first-page":"21221","DOI":"10.1038\/s41598-021-98949-y","article-title":"Antiviral activity of silymarin and baicalein against dengue virus","volume":"11","author":"Low","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2023.12.009_bib0022","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1471-2334-12-314","article-title":"Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1","volume":"12","author":"Rothan","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.xphs.2023.12.009_bib0023","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2174\/0929866525666180530122835","article-title":"Optimization of protein and peptide drugs based on the mechanisms of kidney clearance","volume":"25","author":"Wu","year":"2018","journal-title":"Protein Pept Lett"},{"issue":"9","key":"10.1016\/j.xphs.2023.12.009_bib0024","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1023\/A:1018953309913","article-title":"Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum","volume":"10","author":"Powell","year":"1993","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.xphs.2023.12.009_bib0025","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7150\/ijms.5037","article-title":"Inhibition of dengue virus entry into target cells using synthetic antiviral peptides","volume":"10","author":"Alhoot","year":"2013","journal-title":"Int J Med Sci"},{"issue":"6","key":"10.1016\/j.xphs.2023.12.009_bib0026","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1371\/journal.pntd.0000721","article-title":"Structural optimization and de novo design of dengue virus entry inhibitory peptides","volume":"4","author":"Costin","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.xphs.2023.12.009_bib0027","doi-asserted-by":"crossref","first-page":"e50995","DOI":"10.1371\/journal.pone.0050995","article-title":"Release of dengue virus genome induced by a peptide inhibitor","volume":"7","author":"Lok","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xphs.2023.12.009_bib0028","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2017.11.009","article-title":"The antimicrobial peptide HS-1 inhibits dengue virus infection","volume":"514","author":"Monteiro","year":"2018","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.xphs.2023.12.009_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/v15030705","article-title":"Molecular mechanisms of antiviral agents against dengue virus","volume":"15","author":"Lee","year":"2023","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.xphs.2023.12.009_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114441","article-title":"Patients infected with CRF07_BC have significantly lower viral loads than patients with HIV-1 subtype B: mechanism and impact on disease progression","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.xphs.2023.12.009_bib0031","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00386-20","article-title":"Polyethylene glycol 40-modified peptide with high therapeutic efficacy in simian-human immunodeficiency virus-acutely infected rhesus monkeys","volume":"94","author":"Li","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.xphs.2023.12.009_bib0032","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6807-14-4","article-title":"Synthetic cationic antimicrobial peptides bind with their hydrophobic parts to drug site II of human serum albumin","volume":"14","author":"Sivertsen","year":"2014","journal-title":"BMC Struct Biol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492300535X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492300535X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:46:40Z","timestamp":1758361600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235492300535X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S002235492300535X"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.12.009","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Stabilities and Antiviral Activities of Chemically Modified Peptides Against Dengue Serotypes 1\u20134","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}